At Johnson & Johnson's annual meeting, shareholders voted down a proposal to end use of animals to train surgeons for the company's high-tech surgical tools, according to a report by the San Francisco Chronicle.
CEO William Weldon said J&J already tries to use alternatives when possible. The proposal was presented by a representative of People for the Ethical Treatment of Animals, which placed picketers outside the meeting hotel.
Addressing the company's recently announced plan to acquire medical device-maker Synthes for $21.3 billion, Mr. Weldon said it would give J&J a much bigger share of the market for surgical trauma equipment and orthopedic implants. "It is consistent with our long-term strategy to strengthen our leadership position around the world," he said.
Addressing a recent string of drug recalls by the company, Mr. Weldon told shareholders Johnson & Johnson will be "stronger than ever." The company has gutted the factory responsible for most of the recalls and is rebuilding as a state-of-the-art facility to replace it.
Read the San Francisco Chronicle report on Johnson & Johnson.
Related Articles on Medical Supplies:
North Carolina's Wake Endoscopy Center Selects ProVation MD Software
Johnson & Johnson's Synthes Takeover May Spur More Orthopedic Deals
CEO William Weldon said J&J already tries to use alternatives when possible. The proposal was presented by a representative of People for the Ethical Treatment of Animals, which placed picketers outside the meeting hotel.
Addressing the company's recently announced plan to acquire medical device-maker Synthes for $21.3 billion, Mr. Weldon said it would give J&J a much bigger share of the market for surgical trauma equipment and orthopedic implants. "It is consistent with our long-term strategy to strengthen our leadership position around the world," he said.
Addressing a recent string of drug recalls by the company, Mr. Weldon told shareholders Johnson & Johnson will be "stronger than ever." The company has gutted the factory responsible for most of the recalls and is rebuilding as a state-of-the-art facility to replace it.
Read the San Francisco Chronicle report on Johnson & Johnson.
Related Articles on Medical Supplies:
North Carolina's Wake Endoscopy Center Selects ProVation MD Software
Johnson & Johnson's Synthes Takeover May Spur More Orthopedic Deals